ClinTec International Expands into China, Singapore, and Thailand
UK-based Global Clinical Research Organization , ClinTec International has continued its international expansion by opening fully registered offices in China, Singapore and Thailand—consolidating its presence in the Asia Pacific region. Over the next quarter, strategic moves into South Korea, Taiwan, Malaysia, and Indonesia will also take place. The expansion has also been strengthened by the recent appointment of several regional CRAs plus Mary Pan, Director Asia Pacific who has over 12 years international experience in clinical research.
ClinTec CEO, President and Founder, Dr Buttar commented, “Since ClinTec was established in 1997, entering into the emerging markets has always proved to be a huge success for us and we expect the same from the Asia Pacific market. Several multinational companies in pharmaceutical and clinical nutrition product development are already working in partnership with ClinTec to undertake significant clinical research projects across the region.”
In the current economic climate, pharmaceutical companies are searching for new ways of working and delivering global solutions. As such, they are increasingly looking to enter new markets where revenues have not yet been fully tapped, and for partnerships with global CROs capable of facilitating world-wide multicentre clinical research needs. In the past two years, ClinTec has entered 25 new countries worldwide.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
